Emergent BioSolutions | Passivo Circulante

Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
ANI Pharmaceuticals USD 145.48M 11.12M 2023-12
Exact Sciences USD 514.7M 38.19M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Ironwood Pharmaceuticals USD 276.1M 4.48M 2023-12
Lonza CHF 2.71B 369M 2023-06
Moderna USD 3.02B 1.37B 2023-12
Myriad Genetics USD 155.9M 53.4M 2023-12
Pacira USD 97.38M 3.72M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09



Emergent BioSolutions Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2024.